Akebia Therapeutics | AKBA - Operating Expenses


Akebia Therapeutics reported $63.08M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 270.12M 2.55M Jun/2026
Agios Pharmaceuticals USD 130.77M 10.77M Mar/2026
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alnylam Pharmaceuticals USD 1.06B 160.97M Jun/2026
Amgen USD 11.69B 6.9B Jun/2026
Ardelyx USD 127.27M 7.15M Mar/2026
Astellas Pharma JPY 455.56B 33.8B Jun/2026
AstraZeneca USD 12.22B 4.04B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
BioMarin Pharmaceutical USD 6.32B 5.69B Jun/2026
Celltrion KRW 119.22B 21.46B Mar/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Exelixis USD 380.28M 20.8M Jun/2026
Fresenius Medical Care EUR 4.32B 20.7M Jun/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
Ironwood Pharmaceuticals USD 57.33M 8.63M Dec/2024
J&J USD 17.83B 388M Jun/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Karyopharm Therapeutics USD 61.83M 9.9M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Lexicon Pharmaceuticals USD 20.27M 6.1M Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Moderna USD 960M 817M Jun/2026
Nektar Therapeutics USD 49.12M 8.22M Mar/2026
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organigram Holdings CAD 69.59M 14.08M Mar/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pharma Mar EUR 51.01M 8.73M Jun/2026
Prothena USD 25.29M 1.94M Mar/2026
PTC Therapeutics USD 226.66M 19.64M Mar/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Sarepta Therapeutics USD 387.96M 15.59M Jun/2026
Sartorius EUR 747.8M 9.4M Jun/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tectonic Therapeutic USD 27.3M 5.78M Mar/2026
Tilray USD 237.52M 17.34M Sep/2025
Vanda Pharmaceuticals USD -1.14B 1.6B Dec/2025
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.45B 431.06M Jun/2026